Evaluation of the Jumonji Gene and Risk for Spina Bifida and Congenital Heart Defects [2]

American Journal of Medical Genetics

Volumn 126 A, Issue 2, 2004, Pages 215-217

  Volcik, Kelly A ^a   Zhu, Huiping ^a   Finnell, Richard H ^a   Shaw, Gary M ^b   Canfield, Mark ^c   Lammer, Edward J ^d  

^a TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^b California Birth Defects Monitoring Program   (United States)

^c TEXAS DEPARTMENT OF STATE HEALTH SERVICES   (United States)

^d CHILDREN S HOSPITAL OAKLAND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONGENITAL HEART DISEASE; CONTROLLED STUDY; GENE; GENE CONTROL; GENE SEQUENCE; GENETIC CODE; GENETIC RISK; GENETIC VARIABILITY; HEART DEVELOPMENT; HETEROZYGOSITY; HUMAN; INFANT; JUMONJI GENE; LETTER; MAJOR CLINICAL STUDY; NEURULATION; PHENOTYPE; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SPINA BIFIDA;

CASE-CONTROL STUDIES; CENTERS FOR DISEASE CONTROL AND PREVENTION (U.S.); EUROPEAN CONTINENTAL ANCESTRY GROUP; EXONS; HEART DEFECTS, CONGENITAL; HISPANIC AMERICANS; HUMANS; INTRONS; LINKAGE DISEQUILIBRIUM; NERVE TISSUE PROTEINS; PILOT PROJECTS; RISK FACTORS; SEQUENCE ANALYSIS, DNA; SPINAL DYSRAPHISM; UNITED STATES; VARIATION (GENETICS);

EID: 1842533437     PISSN: 15524825     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (9)

1. Lee Y, Song AJ, Baker R, Micales B, Conway SJ, Lyons GE. 2000. Jumonji, a nuclear protein that is necessary for normal heart development. Circ Res 86:932-938.
2. Motoyama J, Kitajima K, Kojima M, Kondo S, Takeuchi T. 1997. Organogenesis of the liver, thymus, and spleen is affected in jumonji mutant mice. Mech Dev 66:27-37.
3. Rasmussen SA, Lammer EJ, Shaw GM, Finnell RH, McGehee RE Jr, Gallagher M, Romitti PA, Murray JC, National Birth Defects Prevention Study. 2002. Integration ofDNA sample collection into a multi-site birth defects case-control study. Teratology 66:177-184.
4. Romano-Zelekha O, Hirsh R, Blieden L, Green MS, Shohat T. 2001. The risk for congenital heart defects in offspring of individuals with congenital heart defects. Clin Genet 59:325-329.
5. Smith P. 2001. Primary care in children with congenital heart disease. J Pediatr Nurs 16:308-319.
6. Takeuchi T, Yamazaki Y, Katoh-Fukui Y, Tsuchiya R, Kondo S, Motoyama J, Higashinakagawa T. 1995. Gene trap capture of a novel mouse gene, jumonji, required for neural tube formation. Genes Dev 9:1211-1222.
7. Takeuchi T, Kojima M, Nakajima K, Kondo S. 1999. Jumonji gene is essential for the neurulation and cardiac development of mouse embryos with a C3H/He background. Mech Dev 86:29-38.
8. Toyoda M, Kojima M, Takeuchi T. 2000. Jumonji is a nuclear protein that participates in the negative regulation of cell growth. Biochem Biophys Res Commun 274:332-336.
9. Yoon PW, Rasmussen SA, Lynberg MC, Moore CA, Anderka M, Carmichael SL, Costa P, Druschel C, Hobbs CA, Romitti PA, Langlois PH, Edmonds LD. 2001. The National Birth Defects Prevention Study. Public Health Rep 116(S1):32-40.